Product

Technology

Our biomarkers have been derived from a large survey of gene expression changes that are present in prostate cancer cells (Stuart paper). In addition to applying steps to enrich for cancer-specific expression changes we have applied unique "filter" algorithms to discern a meaningful biomarker set that detects prostate cancer with high accuracy:

• Normalized  for cell-type specific expression (Yipeng paper, Cancer Research)
• Corrected for age-related expression changes
• Identified cancer-specific markers expressed in the tumor micro-environment (stroma)

Diagnosis with biomarkers applied to conventional biopsy tissue

• High contrast Immunofluorescence and H&E readout
• Digital image acquisition and storage
• Proprietary histocytometric analysis